Enhancer ID: | E_01_0370 |
Species: | human |
Position : | chr15:99562658-99564658 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | -- |
Pubmed ID: | 30886108 |
Enhancer experiment: | Gene knockdown |
Enhancer experiment description: | We discovered that AMPK activation increases PPAR? via myocyte enhancer factor 2A (MEF2A), which acted as a transcription factor for PPAR?. |
Target gene : | KRT6A |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | We discovered that AMPK activation increases PPAR? via myocyte enhancer factor 2A (MEF2A), which acted as a transcription factor for PPAR?.;KRT6A levels, metastasis?associated factors and the Wnt/??catenin pathway were measured using RT?qPCR and western blotting. |
TF name : | MEF2A(A430079H05Rik) |
TF experiment: | ???? |
TF experiment description: | We discovered that AMPK activation increases PPAR? via myocyte enhancer factor 2A (MEF2A), which acted as a transcription factor for PPAR?.;KRT6A levels, metastasis?associated factors and the Wnt/??catenin pathway were measured using RT?qPCR and western blotting. |
Enhancer function : | We discovered that AMPK activation increases PPAR? via myocyte enhancer factor 2A (MEF2A), which acted as a transcription factor for PPAR?. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
We discovered that AMPK activation increases PPAR? via myocyte enhancer factor 2A (MEF2A), which acted as a transcription factor for PPAR?. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|---|---|---|
MEF2A | CDO in myogenesis | reactome | 29 |
MEF2A | ERK/MAPK targets | reactome | 17 |
MEF2A | Signaling mediated by p38-alpha and p38-beta | pid | 35 |
MEF2A | TGF_beta_Receptor | netpath | 220 |
MEF2A | Hs_p38_MAPK_Signaling_Pathway_WP400_72084 | wikipathways | 28 |